Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics-Reference-Cited by-同舟云学术

Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics

Published:2009-08 Issue:8 Volume:64 Page:1194-1201
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:

Author:

Humbert M.,de Blay F.,Garcia G.,Prud’homme A.,Leroyer C.,Magnan A.,Tunon-de-Lara J.-M.,Pison C.,Aubier M.,Charpin D.,Vachier I.,Purohit A.,Gineste P.,Bader T.,Moussy A.,Hermine O.,Chanez P.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1398-9995.2009.02122.x/fullpdf

Reference25 articles.

1. Asthma;Busse;N Engl J Med,2001

2. Severe asthma in adults: what are the important questions?;Chanez;J Allergy Clin Immunol,2007

3. Costs of asthma are correlated with severity: a 1-yr prospective study;Godard;Eur Respir J,2002

4. The mechanisms, diagnosis, and management of severe asthma in adults;Holgate;Lancet,2006

5. New drugs for asthma;Barnes;Nat Rev Drug Discov,2004

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fyn Kinase in Alzheimer’s Disease: Unraveling Molecular Mechanisms and Therapeutic Implications;Molecular Neurobiology;2024-06-18

2. Drug repurposing for respiratory infections;Progress in Molecular Biology and Translational Science;2024

3. Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development;Expert Opinion on Investigational Drugs;2023-11-02

4. Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis;The Journal of Allergy and Clinical Immunology: In Practice;2023-07

5. COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease;Drug Discovery Today;2023-06